A Phase II, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Relapsing-remitting Multiple Sclerosis Who Have Completed the MT-1303-E04 Study
A Phase II, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Relapsing-remitting Multiple Sclerosis Who Have Completed the MT-1303-E04 Study
To evaluate the long-term safety and tolerability of MT-1303 in subjects with relapsing remitting multiple sclerosis (RRMS).
Inclusion Criteria:
Exclusion Criteria:
City Name, Belgium
City Name, Bulgaria
City Name, Canada
City Name, Croatia
City Name, Czechia
City Name, Finland
City Name, Germany
City Name, Hungary
City Name, Italy
City Name, Lithuania
City Name, Poland
City Name, Russia
City Name, Serbia
City Name, Spain
City Name, Turkey (Türkiye)
City Name, Ukraine
City Name, United Kingdom